Matches in SemOpenAlex for { <https://semopenalex.org/work/W81583187> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W81583187 endingPage "9" @default.
- W81583187 startingPage "84" @default.
- W81583187 abstract "The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding.This is a retrospective subanalysis of the On- TIME 2 trial, a multicenter, controlled randomized trial of the effects of high bolus-dose tirofiban given in the ambulance in STEMI patients. Tirofiban was given on top of aspirin, heparin, and clopidogrel. According to CRUSADE, patients with a moderate to very high baseline risk of bleeding were defined as high risk and patients with a very low or low baseline bleeding risk were defined as low risk. Primary endpoint was net adverse clinical events (NACE) at 30 days (defined as the combined incidence of death, recurrent myocardial infarction, urgent target vessel revascularization, stroke, or non-coronary artery bypass graft [CABG]-related major bleeding).Of 1309 patients, a high bleeding risk was present in 291 patients (22.2%). In these high-risk bleeding patients, tirofiban significantly improved after percutaneous coronary intervention (PCI) ST-segment resolution. Administration of tirofiban in high-risk bleeding patients showed no difference in 30-day major adverse cardiac events (MACE) (9.4% vs 13.0%; P=.330; relative risk [RR], 0.72; 95% confidence interval [CI], 0.37-1.39). However, pretreatment with tirofiban was associated with a nonsignificant increase in non-CABG related bleeding (8.6% vs 3.6%; P=.082; RR, 2.38; 95% CI, 0.90-6.39). The net clinical effect (30-day NACE) of tirofiban in this group was balanced (11.5% vs 15.2%; P=.365; RR, 0.76; 95% CI, 0.41-1.38).Prehospital use of tirofiban in STEMI patients with high risk of bleeding improves post-PCI ST-segment resolution, but increases nonsignificantly the risk of non-CABG related bleeding. The net result is a balanced effect on 30-day NACE. Additional studies should clarify how use of bleeding risk scores should modify medical (antiplatelet) therapy." @default.
- W81583187 created "2016-06-24" @default.
- W81583187 creator A5010936003 @default.
- W81583187 creator A5011535842 @default.
- W81583187 creator A5023867414 @default.
- W81583187 creator A5052518157 @default.
- W81583187 creator A5055705890 @default.
- W81583187 creator A5069661233 @default.
- W81583187 creator A5073193476 @default.
- W81583187 creator A5078909594 @default.
- W81583187 creator A5089329493 @default.
- W81583187 creator A5090903977 @default.
- W81583187 date "2012-03-01" @default.
- W81583187 modified "2023-10-17" @default.
- W81583187 title "Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score." @default.
- W81583187 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22388296" @default.
- W81583187 hasPublicationYear "2012" @default.
- W81583187 type Work @default.
- W81583187 sameAs 81583187 @default.
- W81583187 citedByCount "2" @default.
- W81583187 countsByYear W815831872016 @default.
- W81583187 countsByYear W815831872021 @default.
- W81583187 crossrefType "journal-article" @default.
- W81583187 hasAuthorship W81583187A5010936003 @default.
- W81583187 hasAuthorship W81583187A5011535842 @default.
- W81583187 hasAuthorship W81583187A5023867414 @default.
- W81583187 hasAuthorship W81583187A5052518157 @default.
- W81583187 hasAuthorship W81583187A5055705890 @default.
- W81583187 hasAuthorship W81583187A5069661233 @default.
- W81583187 hasAuthorship W81583187A5073193476 @default.
- W81583187 hasAuthorship W81583187A5078909594 @default.
- W81583187 hasAuthorship W81583187A5089329493 @default.
- W81583187 hasAuthorship W81583187A5090903977 @default.
- W81583187 hasConcept C126322002 @default.
- W81583187 hasConcept C164705383 @default.
- W81583187 hasConcept C168563851 @default.
- W81583187 hasConcept C203092338 @default.
- W81583187 hasConcept C2776335557 @default.
- W81583187 hasConcept C2777849778 @default.
- W81583187 hasConcept C2780400711 @default.
- W81583187 hasConcept C2780739214 @default.
- W81583187 hasConcept C44249647 @default.
- W81583187 hasConcept C45393284 @default.
- W81583187 hasConcept C500558357 @default.
- W81583187 hasConcept C71924100 @default.
- W81583187 hasConcept C82789193 @default.
- W81583187 hasConceptScore W81583187C126322002 @default.
- W81583187 hasConceptScore W81583187C164705383 @default.
- W81583187 hasConceptScore W81583187C168563851 @default.
- W81583187 hasConceptScore W81583187C203092338 @default.
- W81583187 hasConceptScore W81583187C2776335557 @default.
- W81583187 hasConceptScore W81583187C2777849778 @default.
- W81583187 hasConceptScore W81583187C2780400711 @default.
- W81583187 hasConceptScore W81583187C2780739214 @default.
- W81583187 hasConceptScore W81583187C44249647 @default.
- W81583187 hasConceptScore W81583187C45393284 @default.
- W81583187 hasConceptScore W81583187C500558357 @default.
- W81583187 hasConceptScore W81583187C71924100 @default.
- W81583187 hasConceptScore W81583187C82789193 @default.
- W81583187 hasIssue "3" @default.
- W81583187 hasLocation W815831871 @default.
- W81583187 hasOpenAccess W81583187 @default.
- W81583187 hasPrimaryLocation W815831871 @default.
- W81583187 hasRelatedWork W2359983092 @default.
- W81583187 hasRelatedWork W2377126150 @default.
- W81583187 hasRelatedWork W2381301049 @default.
- W81583187 hasRelatedWork W2381545830 @default.
- W81583187 hasRelatedWork W2381583991 @default.
- W81583187 hasRelatedWork W2388093006 @default.
- W81583187 hasRelatedWork W2393684662 @default.
- W81583187 hasRelatedWork W2892052572 @default.
- W81583187 hasRelatedWork W2989084214 @default.
- W81583187 hasRelatedWork W2162886638 @default.
- W81583187 hasVolume "24" @default.
- W81583187 isParatext "false" @default.
- W81583187 isRetracted "false" @default.
- W81583187 magId "81583187" @default.
- W81583187 workType "article" @default.